Abstract
Free full text
The lipopolysaccharide modification regulator PmrA limits Salmonella virulence by repressing the type three-secretion system Spi/Ssa
Abstract
The regulatory protein PmrA controls expression of lipopolysaccharide (LPS) modification genes in Salmonella enterica serovar Typhimurium, the etiologic agent of human gastroenteritis and murine typhoid fever. PmrA-dependent LPS modifications confer resistance to serum, Fe3+, and several antimicrobial peptides, suggesting that the pmrA gene is required for Salmonella virulence. We now report that, surprisingly, a pmrA null mutant is actually hypervirulent when inoculated i.p. into C3H/HeN mice. We establish that the PmrA protein binds to the promoter and represses transcription of ssrB, a virulence regulatory gene required for expression of the Spi/Ssa type three-secretion system inside macrophages. The pmrA mutant displayed heightened expression of SsrB-dependent genes and faster Spi/Ssa-dependent macrophage killing than wild-type Salmonella. A mutation in the ssrB promoter that abolished repression by the PmrA protein rendered Salmonella as hypervirulent as the pmrA null mutant. The antivirulence function of the PmrA protein may limit the acute phase of Salmonella infection, thereby enhancing pathogen persistence in host tissues.
Pathogens possess virulence genes that enable them to invade nonphagocytic cells, to survive within host phagocytic cells, to resist antimicrobial agents and the immune response presented by the host, and/or to kill host cells (1, 2). Paradoxically, pathogens can also have genes that actually reduce their virulence. That is, inactivation of certain genes can decrease the median lethal dose (i.e., LD50) and/or enhance pathogen growth in host tissues (3, 4). However, the function(s) of such antivirulence factors and the contribution(s) they make to a pathogen’s lifestyle remain largely unknown. Here, we establish that an ancestral Salmonella regulator is an antivirulence protein that represses expression of a horizontally acquired locus necessary for survival inside phagocytic cells.
The ancestral two-component system PmrA/PmrB is the major regulator of lipopolysaccharide (LPS) modification genes in Salmonella enterica serovar Typhimurium, the etiologic agent of human gastroenteritis and murine typhoid fever. The regulator PmrA is activated when its cognate sensor PmrB detects mildly acidic pH (5) or the presence of Fe3+ or Al3+ (6), and also when Salmonella experiences low Mg2+, which is detected by the sensor PhoQ (7). Together with the regulator PhoP, PhoQ forms a two-component system that governs virulence functions in Salmonella (8). The PhoP-activated PmrD protein (9) activates the PmrA protein at the posttranslational level (10). The PmrA/PmrB system is active when Salmonella is inside macrophages and during infection of mice (11). PmrA-dependent modifications of the LPS increase bacterial resistance to the antibiotic polymyxin B (6) and host-derived antimicrobial peptides (6, 12), to serum complement (13), and to high concentrations of Fe3+ (14); and they reduce the proinflammatory properties of the LPS (15). However, inactivation of the pmrA gene was reported to have minimal effects on Salmonella’s ability to cause a lethal infection in BALB/c mice when inoculated orally and no effect when inoculated i.p. (16).
Type-three secretion systems (T3SSs) are specialized molecular machines that certain Gram-negative bacteria use to deliver effector proteins into eukaryotic cells (17). These effectors typically manipulate host cell functions, thereby mediating bacterial entry to and/or survival within host tissues (17, 18). Salmonella encodes a T3SS—termed Spi/Ssa—on the Salmonella pathogenicity island (SPI)-2 that is unique in that it translocates effectors into and across the phagosomal membrane (19) and is necessary for bacterial survival within macrophages (20). Expression of spi/ssa genes depends on the SPI-2–encoded SsrB/SpiR two-component system (21), which consists of the sensor SpiR (also known as SsrA) and the DNA binding regulator SsrB (22). An ssrB null mutant is highly attenuated for virulence in mice inoculated by the i.p. route (23), consistent with the notion that the SsrB-dependent Spi/Ssa system is required for pathogen growth in deep tissues.
We now report that inactivation of the pmrA gene renders Salmonella hypervirulent in C3H/HeN mice. We establish that the PmrA protein down-regulates expression of spi/ssa genes by repressing transcription from the ssrB promoter. The hypervirulence of the pmrA null mutant can be recapitulated by rendering the ssrB promoter resistant to repression by PmrA. Our findings suggest that bacterial pathogens use antivirulence factors for optimal fitness in host tissues.
Results
Inactivation of the pmrA Gene Renders Salmonella Hypervirulent.
We reexamined the virulence behavior of a pmrA null mutant in C3H/HeN mice because the PmrA/PmrB system is activated in the presence of Fe3+ (6), and C3H/HeN mice harbor a functional allele of the Nramp1 (also known as Slc11a1) gene, which encodes a protein that mediates iron transport across the phagosomal membrane (24). By contrast, BALB/c mice are Nramp1−/−.
Unexpectedly, the pmrA mutant was more virulent than the isogenic wild-type strain following i.p. inoculation (Fig. 1A). The hypervirulence phenotype was manifested by an earlier time to death than animals infected with wild-type Salmonella (Fig. 1A). This result implied that the PmrA/PmrB system promotes expression of a gene(s) that antagonizes Salmonella virulence and/or represses expression of a virulence determinant(s).
PmrA Represses Transcription of the SPI-2 ssaG Gene.
Given that the pmrA hypervirulence phenotype was observed in Nramp1+/+ mice, we wondered whether the PmrA/PmrB system might regulate expression of SPI-2 genes. Genes located in the SPI-2 pathogenicity island are up-regulated in the spleens of Nramp1+/+ mice relative to those of congenic Nramp1−/− animals (25). Thus, we investigated expression of the SsrB-activated ssaG gene, which is the first gene of a large operon (from ssaG to ssaU) and encodes a component of the Spi/Ssa T3SS (22). We used a set of isogenic strains harboring a plasmid containing the ssaG promoter region fused to a promoterless gfp variant that specifies an unstable GFP (i.e., GFPaav) (26).
There was more fluorescence in the pmrA mutant than in the wild-type strain when bacteria were grown in minimal media at pH 4.6 with high Mg2+ (Fig. 2A), a condition reported to activate SPI-2 genes (27). This behavior was also true when bacteria were grown in minimal media at pH 4.6 with low Mg2+, although there was less of a difference between the two strains. By contrast, the expression was similar in wild-type and pmrA Salmonella in media containing neutral pH regardless of the Mg2+ concentration (Fig. 2A), which is a noninducing condition for SPI-2 genes (27, 28). Control experiments demonstrated that there was no detectable fluorescence in an ssrB mutant strain regardless of growth conditions (Fig. 2A), as anticipated by the established requirement for ssrB in ssaG transcription (21). Moreover, the elevated ssaG expression displayed by the pmrA mutant when grown in minimal media at pH 4.6 with high Mg2+ was restored to wild-type levels by a plasmid expressing the wild-type pmrA gene from a heterologous promoter but not by the plasmid vector (Fig. 2B).
Because Fe3+ is a prime activator of the PmrA/PmrB system (6), we reasoned that it should be possible to modulate expression of SPI-2 genes in wild-type Salmonella by varying the concentrations of Fe3+ in the growth media. Indeed, ssaG expression was greatly reduced as the Fe3+ concentration increased (Fig. 3A). This effect was mediated by PmrA because ssaG expression was no longer responsive to the Fe3+ concentration in a pmrA mutant background (Fig. 3B).
Next, we examined whether the enhanced ssaG expression resulting from inactivation of the pmrA gene was also observed when Salmonella was inside macrophages. This test was important because expression of SPI-2 genes greatly increases upon Salmonella phagocytosis (29, 30), and the PmrA/PmrB system is active inside macrophages (11). We found ssaG expression to be ~30-fold higher at 4 h after internalization by J774A.1 macrophages relative to expression displayed by bacteria grown in LB (Fig. 2C), which is in agreement with previous results (22, 29). Inactivation of the pmrA gene further increased ssaG expression (Fig. 2C), as observed during growth in minimal media (Fig. 2A). We note that the increased ssaG expression does not depend on the presence of a functional Nramp1 protein because J774A.1 macrophages originated from an Nramp1−/− animal (31). Taken together, these results indicate that PmrA functions as a negative regulator of ssaG and potentially of other SPI-2 genes.
PmrA Represses ssaG Transcription Indirectly, by Hindering Expression of the ssaG Activator SsrB.
In principle, PmrA could repress ssaG transcription directly, by binding to the ssaG promoter, or, indirectly, by hindering transcription of an ssaG activator(s) or by furthering expression of an ssaG repressor(s). Sequences resembling a PmrA box (i.e., a direct repeat of the sequence CTTAAT separated by 5 nt present in PmrA-activated promoters; refs. 32–34) were not found in the ssaG promoter region. By contrast, we identified a perfect match to the consensus PmrA box downstream of the mapped transcriptional start site of the ssrB gene (Fig. 4A), which encodes an activator necessary for ssaG transcription (22). This analysis suggested that PmrA might bind to the ssrB promoter hampering ssrB transcription.
The PmrA protein appears to repress ssrB directly because: First, the purified PmrA protein protected the −45 to −16 region from ATG of the ssrB gene in vitro (Fig. 4B), which contains the predicted PmrA binding site in the ssrB promoter (Fig. 4A). Second, chromatin immunoprecipitation experiments revealed that an HA-tagged PmrA expressed from its normal promoter and chromosomal location bound to the ssrB promoter in vivo but not to the ssaG promoter (Fig. 4C). Importantly, the enrichment in ssrB promoter DNA was comparable to that of other known PmrA-regulated genes, including pmrC (Fig. 4C). Third, substitution of four conserved nucleotides in the predicted PmrA box of the ssrB promoter (Fig. 4A) reduced PmrA binding to ssrB promoter DNA in vitro (Fig. 5A) and increased ssaG expression in vivo (Fig. 5B). Notably, the ssaG expression levels exhibited by the strain with the mutation of the PmrA-binding site in the ssrB promoter were similar to those displayed by the pmrA null mutant (Fig. 5B). Furthermore, nucleotide substitution of the PmrA-binding site in the ssrB promoter increased expression of both ssrB and ssaG within the J774A.1 macrophage-like cell line (Fig. 5C) and in bone marrow-derived macrophages prepared from C3H/HeN mice (Fig. S1). We note that the expression levels of the ssrB and ssaG genes in the ssrB promoter mutant were comparable to those in the pmrA mutant (Fig. 5C and Fig. S1) and that the ssrB promoter mutation had no effect on the expression of the PmrA-activated pmrC gene (Fig. 5C).
PmrA’s action at the ssrB promoter is not simply to antagonize activation of ssrB transcription by the SsrB protein because the levels of β-galactosidase activity originating from a plasmid-linked ssrB-lacZ transcriptional fusion were higher in the pmrA mutant than in the wild-type strain and the ssrB mutant (Fig. 4D) even though this fusion was driven by the heterologous lac promoter derivative plac1–6 (35). The only Salmonella sequences present in the plasmid-linked ssrB-lacZ fusion were those located between the ssrB transcription start site and the ssrB start codon, which include the PmrA binding site. By contrast, inactivation of pmrA had no effect on the expression of a similar transcriptional fusion that included the leader region of the spiR gene instead of that of ssrB (Fig. 4D). In addition, similarly low fluorescence levels were displayed by isogenic ssrB and ssrB pmrA strains harboring a plasmid carrying a fusion between the ssaG promoter and a promoterless gfp (aav) gene (Fig. 4E). And inactivation of pmrA in the ssrB promoter mutant background did not alter the levels of ssaG expression (Fig. 5B). These results demonstrated that SsrB is necessary to activate the ssrB promoter even in the absence of PmrA repression. Finally, PmrA’s role as a repressor of ssrB transcription is not simply to prevent the PhoP and OmpR proteins from activating ssrB transcription (21, 36) because there were similarly low levels of ssaG expression in phoP, phoP pmrA, ompR, and ompR pmrA mutants (Fig. S2). Taken together, the results presented in this section indicate that PmrA’s effects on ssaG expression result from direct repression of ssrB transcription.
PmrA Delays Salmonella-Induced Macrophage Death.
To examine the physiological consequences of PmrA repression of ssrB transcription, we examined the kinetics of SPI-2–promoted macrophage death, which is critical for Salmonella virulence (37). We infected macrophages with various Salmonella strains and evaluated cell death by measuring lactate dehydrogenase released from dead or damaged cells. Cell death took place earlier in macrophages infected with the pmrA mutant than with the wild-type strain (Fig. 6). The faster cell death kinetics was also displayed by macrophages infected with the ssrB promoter mutant (Fig. 6). Control experiments showed reduced cell death in macrophages infected with the ssrB mutant (Fig. 6), in agreement with previous reports (38). These data indicate that the PmrA protein delays macrophage death induced by wild-type Salmonella.
PmrA Reduces Salmonella Virulence by Repressing ssrB Transcription.
The results presented above suggested that the hypervirulence phenotype of the pmrA null mutant might be due to PmrA repression of ssrB transcription. If this notion were the case, one would expect: First, that the ssrB promoter mutant that is refractory to repression by the PmrA protein would display the same hypervirulence phenotype as the pmrA null mutant. And second, that a pmrA ssrB promoter double mutant would behave just like pmrA or ssrB promoter single mutants.
We determined that C3H/HeN mice infected with the pmrA mutant or the ssrB promoter mutant died earlier than those infected with the wild-type strain (Fig. 1A). This behavior was also true for the pmrA ssrB promoter double mutant (Fig. 1A). As an independent assay of virulence in vivo, we determined that 5 d after infection the number of bacteria in the liver and spleen of animals infected with the pmrA mutant, the ssrB promoter mutant, and the pmrA ssrB promoter double mutant were similar and were ~100-fold higher than those infected with the wild-type strain (Fig. 1B). These results support the notion that PmrA dampens virulence primarily by repressing transcription of the major regulator of SPI-2 genes.
Discussion
The genes present in a bacterial pathogen can be divided into three distinct groups based on their virulence roles. The best understood group is constituted by the virulence genes, which are genes that upon inactivation reduce the pathogenicity of a pathogen. A second group includes those genes that do not appear to affect virulence because they do not alter pathogenicity when mutated. The third group encompasses the antivirulence genes. These genes are of particular interest because, puzzlingly, their inactivation renders a pathogen hypervirulent.
We have now determined that the regulatory protein PmrA is an antivirulence factor because inactivation of the pmrA gene exacerbated Salmonella virulence in C3H/HeN mice (Fig. 1A). This result was unexpected because pmrA null mutants were known to be more susceptible to serum (13) and to polymyxin B (6), an antibiotic believed to mimic the action of mammalian cationic antimicrobial peptides (12), and also because a pmrA mutant was mildly attenuated when inoculated into BALB/c mice (16), which are exquisitely susceptible to Salmonella infection (LD50 < 10). Unlike BALB/c mice, C3H/HeN mice carry functional Nramp1, which localizes to the phagosomal membrane (39) and hinders growth of several intracellular pathogens that remain within a phagosome (40).
How PmrA Decreases Salmonella Virulence.
The antivirulence function of PmrA can be ascribed to its role as transcriptional repressor of the regulatory gene ssrB, which is essential for expression of genes required for proliferation inside macrophages and systemic infection in mice (23, 41). This antivirulence function is supported by the following: First, the hypervirulence phenotype of the pmrA null mutant could be phenocopied by mutating the PmrA binding site in the ssrB promoter (Fig. 1A). Second, a pmrA ssrB promoter double mutant exhibited the same hypervirulence phenotype of either single mutant (Fig. 1A). And third, SPI-2–dependent macrophage killing was accelerated in both the pmrA mutant and the ssrB promoter mutant (Fig. 6).
The SsrB protein is necessary for transcription of the genes specifying the T3SS encoded in the SPI-2 pathogenicity island as well as its secreted effectors (19, 20). Inactivation of the SPI-2 T3SS enhances Salmonella’s growth inside phagocytes during infection of an animal (42). These results suggest that PmrA repression of ssrB might enable Salmonella to control bacterial proliferation within a cell and to favor dissemination to neighboring cells. Alternatively or in addition, PmrA may enable proper repression of SPI-2 in the intestine, which is a PmrA-inducing environment (43, 44).
What is the identity of the SsrB-regulated gene(s) that must be tightly controlled for a normal course of Salmonella infection? We considered the possibility of the SsrB-repressed sciS being such a gene because its inactivation was reported to increase Salmonella virulence in BALB/c mice infected orally (4). However, we established that an sciS mutant is attenuated for virulence in C3H/HeN mice inoculated i.p. (Fig. S3), which is in contrast to the hypervirulence phenotype exhibited by the pmrA null mutant in the same mouse strain and route of inoculation (Fig. 1A).
Repression of ssrB, the master regulator of SPI-2 genes, constitutes a unique and unexpected function for the PmrA protein, whose best-described role was as the major activator of LPS modification genes (6, 16, 33). Whereas PmrA-dependent LPS modifications can reduce the risk of Salmonella detection by the Toll-like receptor-4 in a mammalian host (15, 45), its role in ssrB repression may reduce expression of Spi/Ssa-secreted effectors that dampen the host immune response (46, 47).
Control of the SPI-2 Virulence Locus.
Several negative regulatory factors have been implicated in transcriptional control of SPI-2 genes. These factors include H-NS (22), YdgT (48), and Hha (49), all of which are nucleoid-associated proteins that recognize and selectively silence the expression of foreign DNA with higher adenine and thymine content relative to the resident genome (50). The PmrA protein directly binds to a specific sequence in the promoter of ssrB, repressing its expression (Figs. 4 and and5).5). Deletion of the genes specifying the nucleoid-associated protein attenuates Salmonella’s virulence in mice (48, 49), whereas preventing PmrA-mediated negative regulation of SsrB increases virulence (Fig. 1). This behavior could perhaps reflect that the regulatory effect of the nucleoid-associated proteins is not limited to SPI-2 genes (50, 51).
That iron limitation increases expression of SPI-2 genes (25, 52) could reflect that under such conditions the PmrA protein is not active (6). Indeed, we could decrease SPI-2 expression by increasing the iron concentration in the growth media (Fig. 3A); this effect was PmrA-dependent because it was not observed in the pmrA null mutant (Fig. 3B). By contrast, the ferric uptake regulator (Fur) does not appear to be involved in this process because an increase in iron would promote Fur dimerization and repression of its target promoters. Because one of Fur’s target promoters is that corresponding to the hns gene (53), and H-NS is known to silence expression of SPI-2 genes (22), the increase in iron should increase expression of SPI-2 genes; however, we observed decreased expression (Fig. 3A).
It is remarkable that the PhoP protein, which is a major regulator of virulence functions in Salmonella (8), exerts two distinct and opposite effects on ssrB expression. It directly activates transcription of the ssrB gene (21). However, it promotes expression of PmrD, a posttranslational activator of PmrA (34), which represses ssrB transcription (Fig. 2). However, expression of PhoP-activated genes is maximal at 5–6 h after internalization, whereas repression of SPI-2 genes by PmrA was detected already 1 h after internalization (Fig. 5C). This result indicates that PmrA is probably activated in response to the signals detected by its cognate sensor PmrB (11). Moreover, it suggests that one of the roles of PhoP in promoting ssrB transcription might be to overcome PmrA-dependent repression of ssrB.
That a given regulator (e.g., PhoP) would promote expression of transcripts that favor virulence and reduce virulence is rare but not unprecedented. First, PhoP is required for transcription of the pcgL gene (7), the inactivation of which increases Salmonella virulence (3), as well as of several genes necessary for virulence (8). And second, PhoP is an activator of both the mgtCBR operon (7), which specifies the virulence protein MgtC (54), as well as of AmgR (55), an antisense RNA that down-regulates the levels of the mgtC transcript (55).
Cumulatively, our data demonstrate that the iron-inducible PmrA/PmrB two-component regulatory system properly tunes the level of SPI-2 induction in phagocytes by repressing ssrB transcription. This regulation is critical for Salmonella’s pathogenicity because lack of PmrA or its binding site on the ssrB promoter results in hypervirulence. Thus, bacterial pathogenicity is determined not only by virulence proteins, but also by antivirulence factors, which may contribute to the overall fitness of a pathogen.
Materials and Methods
Bacterial Strains, Plasmids, Primers, and Growth Conditions.
S. enterica serovar Typhimurium strains were derived from wild-type strain 14028s. Unless otherwise stated, bacteria were grown at 37 °C in LB broth or in N-minimal medium (pH 7.4 or 4.6) (56) supplemented with 0.1% casamino acids, 38 mM glycerol, 1 mM or 10 μM of MgCl2, and the indicated concentration of FeSO4. When necessary, antibiotics were added at the following final concentrations: ampicillin, 50 μg/mL; chloramphenicol, 20 μg/mL; kanamycin, 50 μg/mL, and tetracycline, 10 μg/mL P22 transduction of Salmonella strains was performed as described (57). Escherichia coli DH5α was used as a host for the preparation of plasmid DNA. Bacterial strains and plasmids used in this study are listed in Table S1. Primers used in this study are listed in Table S2.
GFP Assay Salmonella.
Cells expressing a gfp variant from the ssaG promoter were grown in minimal media. The expression of the GFP was measured by using multidetector (VICTOR3; PerkinElmer) with OD600 values. The measured values for GFP expression were divided by 1,000 times the OD600 values.
Identification of PmrA’s Binding to the ssrB Promoter.
To identify the binding of PmrA to the promoter region of the ssrB gene, chromatin immunoprecipitation (55), electrophoretic mobility shift assay (55), and DNase I footprinting assay (34) were carried out as described.
Detailed methods are described in SI Materials and Methods.
Acknowledgments
We thank Tammy Latifi for the DNase I footprinting experiment; Ephraim Fass for constructing plasmid pFPV25AAV-pssaG; and Eunjin Lee, John May, and Nathan Schwalm for comments on the manuscript. This research was supported, in part, by National Institutes of Health Grant AI042236 (to E.A.G.). E.A.G. is an Investigator of the Howard Hughes Medical Institute.
Footnotes
The authors declare no conflict of interest.
This article is a PNAS Direct Submission.
This article contains supporting information online at www.pnas.org/lookup/suppl/10.1073/pnas.1303420110/-/DCSupplemental.
References
Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences
Full text links
Read article at publisher's site: https://doi.org/10.1073/pnas.1303420110
Read article for free, from open access legal sources, via Unpaywall: https://www.pnas.org/content/pnas/110/23/9499.full.pdf
Citations & impact
Impact metrics
Citations of article over time
Alternative metrics
Article citations
Critical role of msgA in invasive capacity and intracellular survivability of Salmonella.
Appl Environ Microbiol, 90(9):e0020124, 13 Aug 2024
Cited by: 0 articles | PMID: 39136487
The multifaceted role of c-di-AMP signaling in the regulation of Porphyromonas gingivalis lipopolysaccharide structure and function.
Front Cell Infect Microbiol, 14:1418651, 12 Jun 2024
Cited by: 0 articles | PMID: 38933693 | PMCID: PMC11199400
Determinants of bacterial survival and proliferation in blood.
FEMS Microbiol Rev, 48(3):fuae013, 01 May 2024
Cited by: 0 articles | PMID: 38734892
Review
How Bacterial Pathogens Coordinate Appetite with Virulence.
Microbiol Mol Biol Rev, 87(3):e0019822, 26 Jun 2023
Cited by: 2 articles | PMID: 37358444 | PMCID: PMC10521370
Review Free full text in Europe PMC
Insights from the molecular docking analysis of colistin with the PmrA protein model from Acinetobacter baumannii.
Bioinformation, 18(1):41-49, 31 Jan 2022
Cited by: 0 articles | PMID: 35815194 | PMCID: PMC9200612
Go to all (24) article citations
Data
Data behind the article
This data has been text mined from the article, or deposited into data resources.
BioStudies: supplemental material and supporting data
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Salmonella pathogenicity island 2 expression negatively controlled by EIIANtr-SsrB interaction is required for Salmonella virulence.
Proc Natl Acad Sci U S A, 107(47):20506-20511, 08 Nov 2010
Cited by: 35 articles | PMID: 21059960 | PMCID: PMC2996713
Identification and genetic characterization of PmrA-regulated genes and genes involved in polymyxin B resistance in Salmonella enterica serovar typhimurium.
Infect Immun, 70(12):6770-6778, 01 Dec 2002
Cited by: 60 articles | PMID: 12438352 | PMCID: PMC133008
The transcriptional regulator SsrB is involved in a molecular switch controlling virulence lifestyles of Salmonella.
PLoS Pathog, 13(7):e1006497, 13 Jul 2017
Cited by: 31 articles | PMID: 28704543 | PMCID: PMC5562331
The biology of the PmrA/PmrB two-component system: the major regulator of lipopolysaccharide modifications.
Annu Rev Microbiol, 67:83-112, 17 Jun 2013
Cited by: 130 articles | PMID: 23799815 | PMCID: PMC8381567
Review Free full text in Europe PMC
Funding
Funders who supported this work.
Howard Hughes Medical Institute
NIAID NIH HHS (3)
Grant ID: R01 AI042236
Grant ID: R56 AI042236
Grant ID: AI042236